CJC-1295-10mg

CJC‑1295 (DAC) is a long‑acting synthetic growth hormone–releasing hormone (GHRH) analogue, supplied as a high‑purity lyophilised peptide for controlled laboratory research. The DAC (Drug Affinity Complex) modification significantly extends the peptide’s half‑life, making it ideal for studies requiring sustained GH‑axis stimulation.

It is widely used in scientific environments investigating endocrine signalling, receptor activation, peptide pharmacokinetics, and comparative GHRH analogue behaviour.

Areas of Research Interest
Long‑Acting GHRH Receptor Activation Studies
Used in controlled environments exploring how extended‑duration GHRH analogues interact with receptors and influence downstream signalling.

Endocrine & GH‑Axis Modelling
Included in laboratory models examining prolonged GH release and associated biochemical cascades.

Peptide Pharmacokinetics Research
Investigated in studies comparing short‑acting vs. long‑acting GHRH analogues (DAC vs. No‑DAC).

Structure–Function Peptide Analysis
Used in research evaluating stability, receptor affinity, and sequence‑specific behaviour of modified GHRH analogues.

Technical Information
Chemical Name: CJC‑1295 (DAC)

Synonyms: DAC‑CJC‑1295, Drug Affinity Complex CJC‑1295

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₈

Molecular Weight: ~3367 g/mol

Sequence: Tetrasubstituted GRF 1‑29 with DAC modification

Classification: Long‑acting synthetic GHRH analogue

Storage Guidelines
Store lyophilised peptide at –20°C or below for long‑term stability.

Short‑term storage at room temperature is acceptable.

After reconstitution, keep at 2–8°C.

Protect from light and moisture.

Solubility
Soluble in sterile water and common aqueous laboratory buffers.

Compliance Notice
For laboratory research use only. Not for human or animal administration.